Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03311308
Title A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Yana Najjar
Indications

melanoma

Therapies

Metformin + Pembrolizumab

Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.